ATE489963T1 - Chaperonin-10-immunosuppression - Google Patents

Chaperonin-10-immunosuppression

Info

Publication number
ATE489963T1
ATE489963T1 AT03769073T AT03769073T ATE489963T1 AT E489963 T1 ATE489963 T1 AT E489963T1 AT 03769073 T AT03769073 T AT 03769073T AT 03769073 T AT03769073 T AT 03769073T AT E489963 T1 ATE489963 T1 AT E489963T1
Authority
AT
Austria
Prior art keywords
donor
recipient animal
cpn10
administration
host disease
Prior art date
Application number
AT03769073T
Other languages
German (de)
English (en)
Inventor
Geoffrey R Hill
Tatjana Banovic
Halle Morton
Alice Christina Cavanagh
Original Assignee
Cbio Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cbio Ltd filed Critical Cbio Ltd
Application granted granted Critical
Publication of ATE489963T1 publication Critical patent/ATE489963T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Glass Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT03769073T 2002-11-06 2003-11-06 Chaperonin-10-immunosuppression ATE489963T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2002952492A AU2002952492A0 (en) 2002-11-06 2002-11-06 Chaperonin 10 immunosuppression
PCT/AU2003/001467 WO2004041300A1 (en) 2002-11-06 2003-11-06 Chaperonin 10 immunosuppression

Publications (1)

Publication Number Publication Date
ATE489963T1 true ATE489963T1 (de) 2010-12-15

Family

ID=28795882

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03769073T ATE489963T1 (de) 2002-11-06 2003-11-06 Chaperonin-10-immunosuppression

Country Status (16)

Country Link
US (3) US7618935B2 (https=)
EP (3) EP2255824B1 (https=)
JP (2) JP4716731B2 (https=)
KR (1) KR101088740B1 (https=)
CN (1) CN100525832C (https=)
AT (1) ATE489963T1 (https=)
AU (1) AU2002952492A0 (https=)
CA (1) CA2505141C (https=)
CY (1) CY1110972T1 (https=)
DE (1) DE60335202D1 (https=)
DK (1) DK1569679T3 (https=)
ES (1) ES2351993T3 (https=)
NZ (1) NZ540433A (https=)
PT (1) PT1569679E (https=)
SI (1) SI1569679T1 (https=)
WO (1) WO2004041300A1 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005204979B2 (en) * 2004-01-16 2010-10-21 Cbio Limited Chaperonin 10 modulation of toll-like receptor-inducible cytokine and chemokine secretion
US20070275890A1 (en) * 2004-01-16 2007-11-29 Johnson Barbara J Chaperonin 10 Modulation Of Toll-Like Receptor-Inducible Cytokine And Chemokine Secretion
US8036710B2 (en) * 2004-05-07 2011-10-11 Qualcomm, Incorporated Power-efficient multi-antenna wireless device
JP2009500430A (ja) * 2005-07-11 2009-01-08 シーバイオ リミテッド シャペロニン１０により誘導される免疫調整方法
AU2006269824B2 (en) * 2005-07-11 2012-04-19 Cbio Limited Chaperonin 10-induced immunomodulation
CN101309934B (zh) 2005-08-31 2014-02-12 悉生物有限公司 修饰的伴侣蛋白10
AU2006303826B2 (en) * 2005-10-20 2012-07-19 Cbio Limited Treatment of hypersensitivity
JP2009511610A (ja) * 2005-10-20 2009-03-19 シービーアイオー リミテッド 過敏症治療
MX2008011167A (es) 2006-03-02 2008-11-12 Cbio Ltd Regulaciòn de respuestas inmunes mediante la modulaciòn de la funciòn de cèlulas presentadoras de antìgenos.
CA2720617A1 (en) * 2008-04-11 2009-10-15 Cbio Limited Modified cpn10 and prr signalling
US20110243921A1 (en) * 2010-03-30 2011-10-06 Cbio Limited Prevention and treatment of cutaneous lupus erythematosus
WO2013158959A1 (en) * 2012-04-19 2013-10-24 Tarix Pharmaceuticals Ltd. Compositions and methods for treatment of graft-versus-host disease
WO2014063194A1 (en) 2012-10-23 2014-05-01 The University Of Sydney Elastic hydrogel
ES2860023T3 (es) 2012-12-10 2021-10-04 Allergan Pharmaceuticals Int Ltd Fabricación de constructos elásticos tridimensionales escalables
KR20230004965A (ko) 2013-08-13 2023-01-06 앨러간 파마슈티컬스 인터내셔널 리미티드 손상 조직의 재생

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2176948C (en) * 1993-11-30 2007-05-15 Halle Morton Chaperonin 10
PT731811E (pt) 1993-11-30 2005-04-29 Univ Queensland Chaperonina 10
US5989804A (en) * 1994-07-08 1999-11-23 New England Medical Center Hospitals, Inc. E6 binding proteins
CA2228379A1 (en) * 1995-08-09 1997-02-20 Schering Corporation Combined use of interleukin-10 and cyclosporin for immunosuppression therapy
US20020142000A1 (en) * 1999-01-15 2002-10-03 Digan Mary Ellen Anti-CD3 immunotoxins and therapeutic uses therefor
CA2383213A1 (en) * 1999-09-10 2001-03-15 Fordham University Methods and compositions for the treatment and prevention of graft rejection using heat shock proteins
GB0028122D0 (en) * 2000-11-17 2001-01-03 St Georges Entpr Ltd Method

Also Published As

Publication number Publication date
AU2002952492A0 (en) 2002-11-21
US7618935B2 (en) 2009-11-17
EP1569679B1 (en) 2010-12-01
WO2004041300A1 (en) 2004-05-21
JP2011088920A (ja) 2011-05-06
EP2255824A1 (en) 2010-12-01
CA2505141C (en) 2012-07-17
KR101088740B1 (ko) 2011-12-01
JP4716731B2 (ja) 2011-07-06
EP1569679A4 (en) 2008-02-27
EP2818179A1 (en) 2014-12-31
EP1569679A1 (en) 2005-09-07
DK1569679T3 (da) 2011-01-10
CA2505141A1 (en) 2004-05-21
NZ540433A (en) 2008-03-28
EP2255824B1 (en) 2014-07-23
SI1569679T1 (sl) 2011-01-31
US20100099605A1 (en) 2010-04-22
CN1735428A (zh) 2006-02-15
US20060198834A1 (en) 2006-09-07
DE60335202D1 (en) 2011-01-13
PT1569679E (pt) 2010-12-14
CY1110972T1 (el) 2015-06-11
US20120082690A1 (en) 2012-04-05
KR20050086428A (ko) 2005-08-30
JP2006508099A (ja) 2006-03-09
US8067361B2 (en) 2011-11-29
CN100525832C (zh) 2009-08-12
ES2351993T3 (es) 2011-02-14

Similar Documents

Publication Publication Date Title
CY1110972T1 (el) Ανοσοκαταστολη με σαπερονινη 10
CO5700767A2 (es) Procedimiento de tratamiento de rechazo de transplantes
WO2004031129A3 (en) Compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection
BR0203650A (pt) Estentor de auto-articulação
PT2163614T (pt) Animais porcinos que carecem de qualquer expressão de alfa 1,3 galactosiltransferase funcional
ATE463256T1 (de) Mittel zur suppression von transplantat- abstossung
EA200300738A1 (ru) Защита, восстановление и усиление эритропоэтинреактивных клеток, тканей и органов
PT1404811E (pt) O monóxido de carbono melhora os resultados nos transplantes de tecidos e de orgãos e suprime a apoptose
EP1676574A3 (en) Methods for promoting survival of transplanted tissues and cells
WO2004039248A3 (en) Repairing or replacing tissues or organs
BR9612821A (pt) Métodos para a prevenção de rejeição de enxerto em transplante e para a produção de uma célula de hospedeiro para terapia genética universal
DK1567171T3 (da) Anvendelse af dextransulfat til behandling af ibmir
WO2004091436A3 (en) Methods and compositions for treating ocular disease
BR0207434A (pt) Uso de agentes de domiciliação acelerada de linfócitos para a fabricação de um medicamento para o tratamento de função retardada de enxertos
ATE260559T1 (de) Sordarinderivate
TR200002847T2 (tr) Biçim VI 5, 6-dikloro-2-(izopropilamino) -1-(beta-L-ribofüranosil) -1H-benzimidazol.
ATE238050T1 (de) 4-cyano-4-deformylsordarizin-derivate
BG104258A (en) 4-cyano-4-deformylsordarin derivatives
NO20016326L (no) Anvendelse av proteinet UK 114 for å hindre avstötning av organtransplantatet
HUP0103107A2 (hu) Allogénikus és xenogénikus T-sejtek ex vivo kezelése gp39 antagonistákkal
RU2004128515A (ru) Способ восстановления кожного покрова при комбинированных радиационно-ожоговых поражениях

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1569679

Country of ref document: EP